Health Catalyst Statistics
Total Valuation
Health Catalyst has a market cap or net worth of $265.18 million. The enterprise value is $325.58 million.
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Health Catalyst has 69.60 million shares outstanding. The number of shares has increased by 9.58% in one year.
| Current Share Class | 69.60M |
| Shares Outstanding | 69.60M |
| Shares Change (YoY) | +9.58% |
| Shares Change (QoQ) | +9.90% |
| Owned by Insiders (%) | 3.18% |
| Owned by Institutions (%) | 80.80% |
| Float | 67.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.17 |
| PS Ratio | 0.73 |
| Forward PS | 0.76 |
| PB Ratio | 0.67 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 106.28 |
| P/OCF Ratio | 57.99 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 130.49 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 1.07.
| Current Ratio | 1.24 |
| Quick Ratio | 1.20 |
| Debt / Equity | 1.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | 161.27 |
| Interest Coverage | -2.33 |
Financial Efficiency
Return on equity (ROE) is -19.80% and return on invested capital (ROIC) is -4.75%.
| Return on Equity (ROE) | -19.80% |
| Return on Assets (ROA) | -4.15% |
| Return on Invested Capital (ROIC) | -4.75% |
| Return on Capital Employed (ROCE) | -9.55% |
| Revenue Per Employee | $207,516 |
| Profits Per Employee | -$48,438 |
| Employee Count | 1,500 |
| Asset Turnover | 0.39 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Health Catalyst has paid $435,000 in taxes.
| Income Tax | 435,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.54% in the last 52 weeks. The beta is 1.53, so Health Catalyst's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | -37.54% |
| 50-Day Moving Average | 3.92 |
| 200-Day Moving Average | 5.96 |
| Relative Strength Index (RSI) | 47.90 |
| Average Volume (20 Days) | 689,780 |
Short Selling Information
The latest short interest is 3.24 million, so 4.65% of the outstanding shares have been sold short.
| Short Interest | 3.24M |
| Short Previous Month | 3.19M |
| Short % of Shares Out | 4.65% |
| Short % of Float | 4.81% |
| Short Ratio (days to cover) | 5.79 |
Income Statement
In the last 12 months, Health Catalyst had revenue of $311.27 million and -$72.66 million in losses. Loss per share was -$1.16.
| Revenue | 311.27M |
| Gross Profit | 143.00M |
| Operating Income | -52.69M |
| Pretax Income | -86.06M |
| Net Income | -72.66M |
| EBITDA | -19.67M |
| EBIT | -52.69M |
| Loss Per Share | -$1.16 |
Full Income StatementBalance Sheet
The company has $341.97 million in cash and $402.37 million in debt, giving a net cash position of -$60.40 million or -$0.87 per share.
| Cash & Cash Equivalents | 341.97M |
| Total Debt | 402.37M |
| Net Cash | -60.40M |
| Net Cash Per Share | -$0.87 |
| Equity (Book Value) | 376.81M |
| Book Value Per Share | 5.42 |
| Working Capital | 83.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.57 million and capital expenditures -$2.08 million, giving a free cash flow of $2.50 million.
| Operating Cash Flow | 4.57M |
| Capital Expenditures | -2.08M |
| Free Cash Flow | 2.50M |
| FCF Per Share | $0.04 |
Full Cash Flow StatementMargins
Gross margin is 45.94%, with operating and profit margins of -16.93% and -23.34%.
| Gross Margin | 45.94% |
| Operating Margin | -16.93% |
| Pretax Margin | -23.20% |
| Profit Margin | -23.34% |
| EBITDA Margin | -6.32% |
| EBIT Margin | -16.93% |
| FCF Margin | 0.80% |
Dividends & Yields
Health Catalyst does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.58% |
| Shareholder Yield | -9.58% |
| Earnings Yield | -27.40% |
| FCF Yield | 0.94% |
Analyst Forecast
The average price target for Health Catalyst is $8.00, which is 109.97% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.00 |
| Price Target Difference | 109.97% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 11.93% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Health Catalyst has an Altman Z-Score of -1.15 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.15 |
| Piotroski F-Score | 4 |